Step by Step

INTRODUCTION

Pathology MOC Activity ID

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.25

Target Audience:

Pathologists, Pathology Residents, Medical Students, Pathology Assistants and Pathology Assistant Students.

Educational Objectives:

Upon completion of this activity, participants will be able to:

  • Improve application of TNM staging criteria to pulmonary carcinomas.
  • Differentiate Adenocarcinoma in situ from early invasive Adenocarcinoma.
  • Recognize micro-invasive Squamous cell carcinoma.
SPECIAL NOTE:
There is no educational content to this course. This course is designed to supplement training that has already occurred. This course is designed to only administer the required post-test and collect CME evaluations.

This course is eligible for The American Board of Pathology SAM credit.

Suggested Additional Reading Resources:

  • Borczuk AC. Assessment of invasion in lung adenocarcinoma classification, including adenocarcinoma in situ and minimally invasive adenocarcinoma. Mod Pathol. 2012: Jan; 25.
  • Travis WD, et al. International association for the study of lung cancer/american thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011: Feb; 6(2):244-85.
  • Jones KD. An update on lung cancer staging. Adv Anat Pathol. 2010; Jan; 17(1):33-7.
  • De Oliveira Duarte Achcar R, et al. Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile. Am J Clin Pathol. 2009: May;131 (5): 694-700.
  • Yousem SA. Peripheral squamous cell carcinoma of lung: patterns of growth with particular focus on airspace filling. Hum Pathol. 2009: Jun; 40 (6):861-7.

Authors:
Samuel A. Yousem, MD — E. Leon Barnes Professor of Anatomic Pathology, Vice Chairman of Anatomic Pathology Services at UPMC, Director of Division of Anatomic Pathology, and Co-Director of the Community Pathology Division.
No relationships with industry relevant to the content of this educational activity have been disclosed.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.